Johnson & Johnson Innovation

The strategic venture capital arm of Johnson & Johnson, investing in healthcare innovation across pharmaceuticals, medical devices, and consumer healthcare.

Corporate VC Active New Brunswick, United States Est. 1973
Visit website ↗
Last updated 2026-07-20
Portfolio
3
in our dataset
Rounds participated
4
Rounds led
0
Rounds' value
$43.0M
total disclosed, rounds participated
Stages
B Round, E Round, G Round, C Round, A Round, Seed, F Round, D Round

About

Johnson & Johnson Innovation (JJDC) is the strategic venture capital arm of Johnson & Johnson. JJDC pursues opportunities to solve critical healthcare needs. Its portfolio companies benefit from the full global capabilities of Johnson & Johnson as JJDC collaborates to drive innovation. JJDC finds transformative ideas and helps them mature into real solutions for today's patients. Guided by a clear, consistent investment strategy aligned with scientific goals, JJDC works hand-in-hand with partners to navigate the path to creating breakthrough health innovations. JJDC invests across sectors—pharmaceuticals, medical devices, and consumer healthcare—and at all stages, from seed-level startups to Series B and beyond. JJDC also makes private investments in public equity. All of its portfolio companies receive the same unwavering commitment. JJDC takes a long-term approach, deploying the full capabilities of the Johnson & Johnson family of companies, including discovery, clinical development, regulatory affairs, manufacturing and commercialization. JJDC's team includes leaders in the healthcare and technology communities, many with deep R&D experience.

Portfolio · 3

DayTwo
Precision Nutrition for Metabolic Disease
2 rounds $43.0M committed Latest: 2019-06
Ramino-Bio
Oral drug for treating cardio-metabolic disease and rare MSUD
1 round Latest: 2018-09
Pi Therapeutics
Inhibitors for Cancer Treatment
1 round Latest: 2017-01

Investment activity

6 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences15

Q&A

What is Johnson & Johnson Innovation's primary investment focus?
Johnson & Johnson Innovation primarily focuses on the Health Tech & Life Sciences sector, with all 15 of its portfolio companies operating in this area.
Can you name some of Johnson & Johnson Innovation's recent exits?
In August 2024, Johnson & Johnson Innovation saw the acquisition of V-Wave for $600M. In May 2022, CartiHeal was acquired by Bioventus.
What is Johnson & Johnson Innovation's investment stage preference?
Johnson & Johnson Innovation invests across various stages, including Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
Which notable companies are in Johnson & Johnson Innovation's current portfolio?
Key companies in Johnson & Johnson Innovation's portfolio include BiomX, which focuses on microbiome therapies, and DayTwo, specializing in precision nutrition for metabolic disease.
What was a significant exit for Johnson & Johnson Innovation in 2021?
In August 2021, Zebra Medical Vision, an AI-based medical imaging solutions company, was acquired by Nanox Vision for $200M.
How many investment rounds has Johnson & Johnson Innovation participated in within the last two years?
Johnson & Johnson Innovation participated in one investment round in March 2022 and another in October 2024.
What is the typical check size for Johnson & Johnson Innovation?
Johnson & Johnson Innovation's investment range is between $2.25M and $98M.
Who are some of the key team members at Johnson & Johnson Innovation?
The team includes Zeev Zehavi and VP Venture Investments.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitejnjinnovation.com/jjdc

Identifiers & details

Founded1973

Radar intelligence

Patents

EPO40

Web history (Wayback)

Domainjnjinnovation.com

Certificate / subdomain footprint

Subdomains56